GB202107713D0 - Combination therapy - Google Patents
Combination therapyInfo
- Publication number
- GB202107713D0 GB202107713D0 GBGB2107713.6A GB202107713A GB202107713D0 GB 202107713 D0 GB202107713 D0 GB 202107713D0 GB 202107713 A GB202107713 A GB 202107713A GB 202107713 D0 GB202107713 D0 GB 202107713D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- combination therapy
- therapy
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2107713.6A GB202107713D0 (en) | 2021-05-28 | 2021-05-28 | Combination therapy |
PCT/EP2022/063158 WO2022248268A1 (en) | 2021-05-28 | 2022-05-16 | Combination therapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2107713.6A GB202107713D0 (en) | 2021-05-28 | 2021-05-28 | Combination therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202107713D0 true GB202107713D0 (en) | 2021-07-14 |
Family
ID=76741420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2107713.6A Ceased GB202107713D0 (en) | 2021-05-28 | 2021-05-28 | Combination therapy |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202107713D0 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
WO2007044515A1 (en) | 2005-10-07 | 2007-04-19 | Exelixis, Inc. | Azetidines as mek inhibitors for the treatment of proliferative diseases |
WO2018146199A1 (en) | 2017-02-08 | 2018-08-16 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
-
2021
- 2021-05-28 GB GBGB2107713.6A patent/GB202107713D0/en not_active Ceased
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
WO2007044515A1 (en) | 2005-10-07 | 2007-04-19 | Exelixis, Inc. | Azetidines as mek inhibitors for the treatment of proliferative diseases |
WO2018146199A1 (en) | 2017-02-08 | 2018-08-16 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
Non-Patent Citations (22)
Title |
---|
"Genbank", Database accession no. CAA78163 |
"Guideline on clinical trials in small populations", 1 February 2007 |
ANGEW CHEM. INTL. ED. ENGL., vol. 33, 1994, pages 183 - 186 |
CARTER, P., NATURE REVIEWS IMMUNOLOGY, vol. 6, 2006, pages 343 - 357 |
CAS , no. 7 95058-81-4 |
CLACKSON ET AL., NATURE, vol. 352, 1991, pages 624 - 628 |
FLYNN ET AL., MOL CANCER THER, 2016 |
HAMANN P., EXPERT OPIN. THER. PATENTS, vol. 15, no. 9, 2005, pages 1087 - 1103 |
JANEWAY, C.TRAVERS, P.WALPORT, M.SHLOMCHIK: "Immuno Biology", 2001, GARLAND PUBLISHING |
KOHLER ET AL., NATURE, vol. 256, 1975, pages 495 |
KOVTUN ET AL., CANCER RES., vol. 66, no. 4, 2006, pages 2328 - 2337 |
LAMBERT J., CURRENT OPIN. IN PHARMACOL., vol. 5, 2005, pages 543 - 549 |
LONBERG, CURR. OPINION, vol. 20, no. 4, 2008, pages 450 - 459 |
MARKS ET AL., J. MOL. BIOL., vol. 222, 1991, pages 581 - 597 |
MORRISON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 6851 - 6855 |
PAYNE, G., CANCER CELL, vol. 3, 2003, pages 207 - 212 |
SYRIGOSEPENETOS, ANTICANCER RESEARCH, vol. 19, 1999, pages 605 - 614 |
TOSCHI ET AL., FUTURE ONCOLOGY, vol. 1, no. 1, 2005, pages 7 - 17 |
TRAIL ET AL., CANCER IMMUNOL. IMMUNOTHER., vol. 52, 2003, pages 328 - 337 |
WU ET AL., NATURE BIOTECH., vol. 23, no. 9, 2005, pages 1137 - 1145 |
XIE ET AL., EXPERT. OPIN. BIOL. THER., vol. 6, no. 3, 2006, pages 281 - 291 |
ZAMMARCHI ET AL., AACR ANNUAL MEETING, 14 April 2018 (2018-04-14) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202111288D0 (en) | Combination therapy | |
GB202108303D0 (en) | Therapy | |
GB202004189D0 (en) | Combination therapy | |
IL304223A (en) | Combination therapy | |
GB202109377D0 (en) | Combination therapy | |
GB202109375D0 (en) | Combination therapy | |
GB202109373D0 (en) | Combination therapy | |
GB202107824D0 (en) | Combination therapy | |
GB202107706D0 (en) | Combination therapy | |
GB202107709D0 (en) | Combination therapy | |
GB202107713D0 (en) | Combination therapy | |
GB202104037D0 (en) | Combination therapy | |
GB202015916D0 (en) | Combination therapy | |
GB202012161D0 (en) | Combination therapy | |
GB202009178D0 (en) | Combination therapy | |
GB202117706D0 (en) | Therapy | |
GB202111035D0 (en) | Therapy | |
GB202109893D0 (en) | PeptiBAC therapy | |
GB202104427D0 (en) | Therapy | |
GB202103164D0 (en) | Therapy | |
GB202102211D0 (en) | PeptiBAC therapy | |
GB202019218D0 (en) | Therapy | |
GB202017598D0 (en) | Therapy | |
GB202017554D0 (en) | Therapy | |
GB202015780D0 (en) | Therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |